AbCellera Biologics Inc vs LyondellBasell Industries NV — how do they compare? AbCellera Biologics Inc trades at $8.97 (market cap $2.85B), while LyondellBasell Industries NV trades at $63.98 (market cap $20.24B). The key difference: LyondellBasell Industries NV is far larger — about 7.1× AbCellera Biologics Inc's market cap, and LyondellBasell Industries NV pays a 6.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | LYB | |
|---|---|---|
Market Cap | $2.85B | $20.24B |
Sector | Health | Basic Materials |
52-Week High | $9.76 | $82.38 |
52-Week Low | $2.78 | $42.28 |
Enterprise Value | $2.45B | $31.83B |
Dividend Yield | — | 6.58% |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →